GO:1900015 regulation of cytokine production involved in inflammatory response: Inflammatory Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900015 describes any process that modulates the frequency, rate or extent of cytokine production specifically during an inflammatory response.
• This term is a biological process that sits at the interface of innate and adaptive immunity, controlling how much and how long cytokines are made [1, 6].
• Dysregulation of this process is central to periodontitis, atherosclerosis, hypertension, and neuroinflammation [1, 2, 4, 6, 7].
• Key regulatory nodes include ZFP36 family RNA-binding proteins, IL-6, TNF-alpha, and adiponectin/AdipoR1 signaling [2, 4, 5, 8].
• Researchers study GO:1900015 using knockout, knock-in, overexpression cell models, CRISPR library screening, and cytokine profiling [2, 5, 8].
• EDITGENE provides end-to-end CRISPR services to dissect causal genes within this inflammatory cytokine regulatory network.
Description
GO:1900015, regulation of cytokine production involved in inflammatory response, is a Gene Ontology biological process term that captures any process modulating the frequency, rate or extent of cytokine production during inflammation. Cytokines are small secreted proteins that coordinate immune cell recruitment, activation, and resolution of inflammation, and their production must be tightly controlled to avoid tissue damage [1, 6]. This term is distinct from general cytokine production because it specifically qualifies the inflammatory context, linking it to acute and chronic inflammatory diseases [1, 2]. Understanding GO:1900015 is therefore essential for immunologists, cell biologists, and drug developers who need to identify causal regulators of inflammatory cytokine output [2, 5]. The process is not a single pathway but a convergence point for transcriptional, post-transcriptional, and signaling mechanisms that together set the inflammatory cytokine set point [5, 7]. Because many chronic diseases, including periodontitis, atherosclerosis, and hypertension, involve sustained dysregulation of this process, GO:1900015 has become a high-value target for functional genomics and CRISPR screening [1, 2, 6, 7]. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the term, its mechanisms, key genes, disease links, and experimental models.
regulation of cytokine production involved in inflammatory response At A Glance
| GO ID | GO:1900015 |
|---|---|
| GO term | regulation of cytokine production involved in inflammatory response |
| Ontology | biological_process |
| Synonym | regulation of cytokine production involved in acute inflammatory response |
| Definition | Any process that modulates the frequency, rate or extent of cytokine production involved in inflammatory response. |
| Major function | Controls the amount, timing, and duration of cytokine release during inflammation. |
| Regulatory direction | Includes both positive and negative regulation of inflammatory cytokine production. |
| Cellular context | Immune cells, fibroblasts, endothelial cells, and tissue-resident cells. |
| Disease relevance | Periodontitis, atherosclerosis, hypertension, neuroinflammation, and cytokine-driven pathologies. |
What Is GO:1900015?
According to QuickGO, GO:1900015 is defined as any process that modulates the frequency, rate or extent of cytokine production involved in inflammatory response. In practical terms, it covers all molecular events that increase or decrease the amount of cytokines made by a cell during inflammation, including changes in transcription, mRNA stability, translation, and secretion. The term is a biological process and includes both positive and negative regulation, meaning it encompasses pro-inflammatory amplification and anti-inflammatory feedback. Its synonym, regulation of cytokine production involved in acute inflammatory response, highlights its relevance to acute inflammation, though the term also applies to chronic inflammatory settings. Researchers use GO:1900015 to annotate genes and pathways that control cytokine output specifically in the context of an inflammatory response, distinguishing them from housekeeping cytokine production.
Why Is regulation of cytokine production involved in inflammatory response Important in Cell Biology?
GO:1900015 matters because inflammatory cytokines are double-edged swords: they are required for host defense and tissue repair, but their overproduction drives chronic inflammatory diseases, tissue destruction, and metabolic dysfunction [1, 6]. The term provides a standardized way to annotate genes that specifically tune cytokine output during inflammation, enabling reproducible comparisons across studies and species [1, 2]. In periodontitis, for example, dysregulated cytokine production by periodontal ligament cells and gingival fibroblasts contributes to tissue breakdown [2, 8]. In hypertension and atherosclerosis, innate immune cytokine regulation influences vascular remodeling and plaque stability [6, 7]. Consequently, genes annotated to GO:1900015 are candidate therapeutic targets and biomarkers, and functional validation using CRISPR models is a key step in translational research [5, 8].
• Provides a controlled vocabulary for annotating genes that modulate inflammatory cytokine production.
• Central to understanding acute and chronic inflammatory disease mechanisms [1, 2].
• Links innate immune sensing to adaptive immune activation through cytokine output.
• Relevant to periodontitis, where cytokines such as IL-6 and TNF-alpha drive tissue destruction [2, 8].
• Implicated in cardiovascular disease, including atherosclerosis and hypertension [6, 7].
• Involved in neuroinflammation and microglial polarization in stress-related disorders.
• Post-transcriptional regulators such as ZFP36 family proteins are key nodes in this process.
• Supports drug discovery by identifying causal regulators of cytokine production [5, 7].
• Enables CRISPR screening to map genetic dependencies in inflammatory cytokine regulation [5, 8].
• Facilitates cross-species comparison of inflammatory mechanisms in model organisms [4, 6].
What Happens During regulation of cytokine production involved in inflammatory response?
Initiation and sensing of inflammatory signals
In simple terms: The process starts when cells detect danger signals or inflammatory cues.
Regulation of cytokine production involved in inflammatory response begins with the recognition of pathogen-associated or damage-associated molecular patterns by innate immune receptors, which triggers intracellular signaling cascades [1, 6]. In periodontal disease, bacterial components stimulate periodontal ligament cells and gingival fibroblasts to initiate pro-inflammatory cytokine production. This sensing phase sets the stage for transcriptional and post-transcriptional control of cytokine genes.
Transcriptional control of cytokine genes
In simple terms: Cells switch on cytokine genes by activating transcription factors.
Inflammatory signaling activates transcription factors such as NF-kB and AP-1, which drive the expression of cytokines including TNF-alpha, IL-1beta, and IL-6 [1, 7]. The rate of transcription directly influences the frequency and extent of cytokine production, making transcriptional regulation a core component of GO:1900015. In periodontitis, this transcriptional activation in fibroblasts and immune cells contributes to sustained cytokine release [2, 8].
Post-transcriptional regulation and mRNA stability
In simple terms: After cytokine mRNAs are made, their lifespan is controlled to fine-tune output.
RNA-binding proteins of the ZFP36 family promote the degradation of cytokine mRNAs, thereby limiting inflammatory cytokine production. This post-transcriptional layer is essential for preventing excessive inflammation and is a key mechanism within GO:1900015. Dysregulation of ZFP36 proteins has been linked to inflammatory diseases, highlighting the importance of mRNA stability control.
Translational and secretory control
In simple terms: Cells also control how much cytokine protein is made and released.
Translational efficiency and secretory pathways further modulate the amount of mature cytokine available during inflammation [3, 7]. Cytokines such as IL-6 can act on gingival fibroblasts to amplify or dampen further cytokine production, creating feedback loops. This level of regulation ensures that cytokine production is matched to the inflammatory context.
Resolution and negative feedback
In simple terms: The process includes brakes that shut down cytokine production after inflammation.
Negative feedback mechanisms, including anti-inflammatory cytokines and regulatory RNA-binding proteins, reduce cytokine production to resolve inflammation [5, 7]. In hypertension, innate immune activation can shift the balance toward sustained cytokine production, contributing to pathology. Proper resolution is as important as initiation for maintaining tissue homeostasis [1, 6].
Key Genes Involved in GO:1900015 regulation of cytokine production involved in inflammatory response
The following genes and proteins are experimentally implicated in the regulation of cytokine production involved in inflammatory response, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNF | Pro-inflammatory cytokine whose production is a key output of GO:1900015 | Central to periodontitis and atherosclerosis models [1, 7] |
| IL6 | Pro-inflammatory cytokine that amplifies inflammatory responses | Studied in gingival fibroblasts and periodontitis |
| IL1B | Pro-inflammatory cytokine driving acute inflammation | Target in innate immune and vascular studies [1, 6] |
| ZFP36 | RNA-binding protein that destabilizes cytokine mRNAs | Post-transcriptional brake on inflammation |
| ZFP36L1 | ZFP36 family member regulating cytokine mRNA stability | Implicated in inflammatory disease mechanisms |
| ZFP36L2 | ZFP36 family member controlling cytokine production | Potential therapeutic node in inflammation |
| ADIPOR1 | Receptor for adiponectin mediating anti-inflammatory signaling | Linked to microglial polarization and neuroinflammation |
| ADIPOQ | Adiponectin ligand that modulates inflammatory cytokine production | Studied in stress-induced neuroinflammation |
| NFKB1 | Transcription factor activating cytokine gene expression | Core transcriptional regulator in inflammation |
| RELA | NF-kB subunit driving pro-inflammatory cytokine transcription | Key node in innate immune signaling [1, 6] |
| MAPK1 | Kinase in signaling cascades that regulate cytokine production | Involved in inflammatory signal transduction |
| MAPK14 | p38 MAPK regulating cytokine synthesis | Target in inflammatory disease research [1, 7] |
| STAT3 | Transcription factor downstream of IL-6 signaling | Mediates cytokine feedback in fibroblasts |
| SOCS3 | Negative regulator of cytokine signaling | Controls resolution of inflammation |
| IL10 | Anti-inflammatory cytokine that suppresses pro-inflammatory cytokine production | Feedback regulator in GO:1900015 |
| CCL2 | Chemokine whose production is regulated during inflammation | Relevant to immune cell recruitment |
| PTGS2 | Enzyme linked to inflammatory mediator production | Studied in periodontal inflammation [1, 2] |
How Is regulation of cytokine production involved in inflammatory response Regulated?
Regulation of cytokine production involved in inflammatory response is itself controlled at multiple levels. Adiponectin/AdipoR1 pathway activation shifts microglial polarization and reduces neuroinflammatory cytokine production in chronic stress models. ZFP36 family RNA-binding proteins provide a post-transcriptional brake by promoting cytokine mRNA decay. In periodontal ligament cells, pro-inflammatory cytokine production is regulated by signaling pathways that respond to bacterial challenge and inflammatory mediators. IL-6 signaling in gingival fibroblasts can further modulate cytokine output, creating autocrine feedback. These layers ensure that cytokine production is dynamic and context-dependent, and they represent actionable targets for experimental perturbation [4, 5, 8].
regulation of cytokine production involved in inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL6 | Periodontitis | Gingival fibroblast knockout and overexpression |
| TNF | Atherosclerosis | Endothelial cell knock-in of risk variants |
| ZFP36 | Inflammatory diseases | Macrophage knockout for cytokine mRNA stability |
| ADIPOR1 | Stress-induced neuroinflammation | Microglial overexpression and knockout |
| IL10 | Chronic inflammation | Knock-in reporter for cytokine feedback |
Periodontitis
Periodontitis is a chronic inflammatory disease in which dysregulated cytokine production drives tissue destruction. Periodontal ligament cells and gingival fibroblasts produce pro-inflammatory cytokines such as IL-6 and TNF-alpha in response to bacterial stimuli, and this production is a direct manifestation of GO:1900015 [2, 8]. The regulation of these cytokines by host factors influences disease severity and progression.
Atherosclerosis and cardiovascular disease
In atherosclerosis, the balance between pro-atherogenic and anti-atherogenic cytokines is critical for plaque development and stability. Innate immune responses in hypertension also involve altered cytokine production that contributes to vascular dysfunction. GO:1900015 provides a framework for annotating genes that control these cytokine balances in cardiovascular tissues [6, 7].
Neuroinflammation and stress-related disorders
Chronic unpredictable stress induces hippocampal neuroinflammation, and running exercise alleviates this by shifting microglial M1/M2 polarization through adiponectin/AdipoR1 signaling. This shift involves changes in cytokine production that fall under GO:1900015. The findings highlight the term's relevance to stress-related neuropsychiatric conditions.
Cytokine-driven endocrine and metabolic dysfunction
Cytokines can influence steroidogenesis and endocrine function, linking inflammatory cytokine regulation to metabolic and reproductive physiology. Although the exact mechanisms are context-dependent, the intersection of GO:1900015 with steroidogenesis underscores the broad impact of cytokine regulation.
From regulation of cytokine production involved in inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase inflammatory cytokine production? | CRISPR knockout in macrophages or fibroblasts [5, 8] |
| Does a disease-associated point mutation alter cytokine regulation? | Point-mutation knock-in in immune cells |
| Does a regulatory element control cytokine gene expression? | Knock-in of reporter or tagged allele |
| Does overexpression of an anti-inflammatory factor suppress cytokines? | Overexpression cell model |
| Which genes are required for cytokine production under inflammatory stimulation? | CRISPR library screening |
| How does a candidate gene affect cytokine mRNA stability? | Knockout combined with RNA stability assays |
How to Study the regulation of cytokine production involved in inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Secreted cytokine protein levels | Quantifying inflammatory output in cell models [2, 8] |
| Luminex | Multiplex cytokine concentrations | Profiling multiple cytokines in one sample |
| RNA-seq | Global mRNA expression changes | Identifying transcriptional regulators of cytokine genes |
| qPCR | Specific cytokine mRNA levels | Validating changes in cytokine gene expression |
| mRNA stability assay | Cytokine mRNA half-life | Assessing post-transcriptional regulation by ZFP36 |
| CRISPR knockout screening | Gene requirement for cytokine production | Discovery of novel regulators in inflammatory response |
| Immunofluorescence | Cytokine protein localization and expression | Single-cell analysis of inflammatory activation |
Cytokine profiling assays
ELISA, Luminex, and cytokine array platforms measure secreted cytokine levels and are the primary readout for GO:1900015 activity [2, 8]. These methods quantify the output of the regulatory process and are used to compare knockout, knock-in, and overexpression models [4, 8].
Transcriptional and post-transcriptional analysis
RNA-seq and qPCR measure cytokine mRNA levels, while mRNA stability assays assess post-transcriptional regulation by factors such as ZFP36. These approaches distinguish transcriptional from post-transcriptional control within GO:1900015.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens can identify genes that regulate inflammatory cytokine production under defined stimulation conditions. Hits are validated individually using targeted knockout or overexpression.
Imaging and reporter systems
Reporter cell lines and immunofluorescence can visualize cytokine promoter activity and protein localization in single cells [1, 4]. These tools help resolve heterogeneity in cytokine production within a population.
How CRISPR Can Be Used to Study GO:1900015 regulation of cytokine production involved in inflammatory response
Knockout
CRISPR knockout of candidate genes such as ZFP36 or IL6 in immune or fibroblast cell lines can test whether the gene is required for inflammatory cytokine production [5, 8]. Knockout models are used to measure changes in cytokine secretion and mRNA stability.
Point Mutation
Point-mutation knock-in can model disease-associated variants in cytokine regulatory genes and assess their impact on GO:1900015 activity. This approach is valuable for dissecting causal variants in inflammatory disease loci.
Knock-in
Knock-in of reporter genes or epitope tags at endogenous cytokine loci enables real-time monitoring of cytokine production during inflammation. Tagged knock-in also facilitates chromatin and RNA immunoprecipitation studies.
Overexpression
Overexpression of anti-inflammatory regulators such as ADIPOR1 or IL10 can suppress inflammatory cytokine production and test sufficiency in the pathway [4, 7]. Overexpression models complement loss-of-function studies to establish causality.
How EDITGENE Supports regulation of cytokine production involved in inflammatory response Research
Researchers studying regulation of cytokine production involved in inflammatory response-related genes often need to determine whether a candidate gene is causally involved in controlling cytokine output, and CRISPR-based models provide the most direct way to establish that causality. EDITGENE offers a comprehensive suite of services to generate and validate such models, from single-gene knockout to genome-wide screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of cytokine production involved in inflammatory response research.
Frequently Asked Questions About regulation of cytokine production involved in inflammatory response
What is GO:1900015?
GO:1900015 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of cytokine production involved in inflammatory response.
What genes are involved in regulation of cytokine production involved in inflammatory response?
Key genes include TNF, IL6, IL1B, ZFP36 family members, ADIPOR1, NFKB1, and STAT3, among others [1, 2, 4, 5, 8].
How is cytokine production regulated during inflammation?
It is regulated at transcriptional, post-transcriptional, translational, and secretory levels, with feedback mechanisms that resolve inflammation [1, 5, 7].
What diseases are linked to GO:1900015?
Periodontitis, atherosclerosis, hypertension, and stress-induced neuroinflammation are among the diseases linked to dysregulated inflammatory cytokine production [1, 2, 4, 6, 7].
What is the role of ZFP36 in inflammatory cytokine production?
ZFP36 family RNA-binding proteins promote the degradation of cytokine mRNAs, acting as a post-transcriptional brake on inflammation.
How can CRISPR be used to study GO:1900015?
CRISPR knockout, knock-in, point mutation, and overexpression models can test whether specific genes regulate inflammatory cytokine production [5, 7, 8].
What cell models are suitable for studying inflammatory cytokine regulation?
Macrophages, gingival fibroblasts, periodontal ligament cells, endothelial cells, and microglia are commonly used models [2, 4, 7, 8].
What is the difference between GO:1900015 and general cytokine production?
GO:1900015 specifically qualifies cytokine production in the context of an inflammatory response, whereas general cytokine production may occur in other contexts.
How does adiponectin signaling affect neuroinflammation?
Adiponectin/AdipoR1 pathway activation shifts microglial polarization and reduces neuroinflammatory cytokine production in chronic stress models.
What methods measure cytokine production in inflammation research?
ELISA, Luminex, RNA-seq, qPCR, mRNA stability assays, and CRISPR screens are commonly used [2, 5, 7, 8].
Conclusion
GO:1900015, regulation of cytokine production involved in inflammatory response, is a central biological process that integrates signaling, transcription, and post-transcriptional control to set the inflammatory cytokine output of cells. Its dysregulation underlies major chronic diseases, including periodontitis, atherosclerosis, and neuroinflammation, making it a high-priority area for functional genomics [1, 2, 4, 6, 7]. CRISPR-based models, combined with cytokine profiling and screening, provide robust tools to identify and validate causal regulators within this process [5, 8]. EDITGENE supports these efforts with comprehensive gene editing and bioinformatics services tailored to inflammatory cytokine research.
References
- 1. Cekici A et al.. 2014. Inflammatory and immune pathways in the pathogenesis of periodontal disease.. Periodontol 2000 64(1):57-80 PMID: 24320956
- 2. Nilsson BO. 2021. Mechanisms involved in regulation of periodontal ligament cell production of pro-inflammatory cytokines: Implications in periodontitis.. J Periodontal Res 56(2):249-255 PMID: 33305420
- 3. Bornstein SR et al.. 2004. Cytokines and steroidogenesis.. Mol Cell Endocrinol 215(1-2):135-41 PMID: 15026186
- 4. Liu L et al.. 2024. Running exercise alleviates hippocampal neuroinflammation and shifts the balance of microglial M1/M2 polarization through adiponectin/AdipoR1 pathway activation in mice exposed to chronic unpredictable stress.. Mol Psychiatry 29(7):2031-2042 PMID: 38361125
- 5. Makita S et al.. 2021. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.. Front Immunol 12:711633 PMID: 34276705
- 6. De Sanctis JB. 2022. Innate Immune Response in Hypertension.. Curr Pharm Des 28(36):2984-2990 PMID: 36154596
- 7. Ray M et al.. 2019. Regulation of pro- and anti-atherogenic cytokines.. Cytokine 122:154175 PMID: 29221669
- 8. Naruishi K et al.. 2018. Biological effects of interleukin-6 on Gingival Fibroblasts: Cytokine regulation in periodontitis.. J Cell Physiol 233(9):6393-6400 PMID: 29574949
